Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Inspiremd Inc (NSPR)

Inspiremd Inc (NSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 83,471
  • Shares Outstanding, K 42,371
  • Annual Sales, $ 7,010 K
  • Annual Income, $ -32,010 K
  • EBIT $ -47 M
  • EBITDA $ -47 M
  • 60-Month Beta 0.70
  • Price/Sales 11.79
  • Price/Cash Flow N/A
  • Price/Book 1.27

Options Overview Details

View History
  • Implied Volatility 54.58% (-31.85%)
  • Historical Volatility 88.48%
  • IV Percentile 7%
  • IV Rank 2.93%
  • IV High 904.07% on 10/29/25
  • IV Low 28.94% on 09/04/25
  • Expected Move (DTE 3) 0.0850 (4.38%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 617
  • Volume Avg (30-Day) 183
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 1,059
  • Open Int (30-Day) 7,609
  • Expected Range 1.8550 to 2.0250

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.22
  • Number of Estimates 1
  • High Estimate -0.22
  • Low Estimate -0.22
  • Prior Year -0.19
  • Growth Rate Est. (year over year) -15.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6900 +14.79%
on 11/20/25
2.2200 -12.61%
on 11/17/25
-0.1700 (-8.06%)
since 11/14/25
3-Month
1.5900 +22.01%
on 11/11/25
2.5650 -24.37%
on 10/06/25
-0.4700 (-19.50%)
since 09/16/25
52-Week
1.5900 +22.01%
on 11/11/25
3.7980 -48.92%
on 02/25/25
-0.9600 (-33.10%)
since 12/16/24

Most Recent Stories

More News
RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors

ALISO VIEJO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST)  – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following...

RXST : 12.76 (+1.92%)
KMTS : 27.00 (+1.96%)
NSPR : 1.9400 (-1.52%)
AXNX : 70.98 (+0.75%)
InspireMD Initiates CGUARDIANS II Clinical Trial for CGuard Prime Carotid Stent System

InspireMD enrolls first patient in CGUARDIANS II trial for CGuard Prime Stent System in TCAR procedures.Quiver AI SummaryInspireMD, Inc. has announced the enrollment of the first patient in its CGUARDIANS...

NSPR : 1.9400 (-1.52%)
InspireMD, Inc. Appoints Scott R. Ward to Board of Directors to Drive Stroke Prevention Innovation

InspireMD appoints Scott R. Ward to its Board, enhancing expertise ahead of potential U.S. approval for CGuard Prime stent.Quiver AI SummaryInspireMD, Inc. has announced the appointment of Scott R. Ward,...

NSPR : 1.9400 (-1.52%)
NAMSA and InspireMD Announce Strategic Outsourcing Partnership to Accelerate New Product Development

NAMSA , a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, and InspireMD, Inc . (Nasdaq: NSPR), developer of the CGuardâ„¢ Embolic Prevention...

NSPR : 1.9400 (-1.52%)
InspireMD Reports Second Quarter 2022 Financial Results and Provides Business Update

- Generated 47.8% growth in CGuardâ„¢ revenue year-over-year - - Delivered several presentations at LINC 2022 featuring CGuardâ„¢ EPS, including a...

NSPR : 1.9400 (-1.52%)
InspireMD to Report Second Quarter 2022 Financial Results on August 9, 2022, and Provide Corporate Business Update

- Conference call and webcast to be held at 8:30 a.m. EDT - TEL AVIV, Israel, Aug. 02, 2022 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR),...

NSPR : 1.9400 (-1.52%)
InspireMD Announces Appointment of Endovascular Pioneer Dr. Juan Parodi as Strategic Advisor

Credited with performing the first ever endovascular repair procedure in 1990...

NSPR : 1.9400 (-1.52%)
InspireMD Provides Highlights from Recent Presentations and Live Case Transmission at LINC 2022

Successful live case transmission again demonstrated CGuard’s™ differentiated patient protection features and ease of use...

NSPR : 1.9400 (-1.52%)
InspireMD’s CGuard™ Embolic Prevention Stent System to be Featured in Clinical Presentations and a Live Case Transmission at LINC 2022

Live case transmission designed to demonstrate ease-of-use and exceptional patient safety features of CGuardâ„¢ Embolic Prevention System (EPS) ...

NSPR : 1.9400 (-1.52%)
InspireMD Reports First Quarter 2022 Financial Results and Business Update

           - 20% growth in CGuard™ revenue Year-over-Year -            - C-Guardian FDA IDE Trial Completes First European Enrollment -            - Held...

NSPR : 1.9400 (-1.52%)

Business Summary

InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous...

See More

Key Turning Points

3rd Resistance Point 2.0800
2nd Resistance Point 2.0300
1st Resistance Point 1.9850
Last Price 1.9400
1st Support Level 1.8900
2nd Support Level 1.8400
3rd Support Level 1.7950

See More

52-Week High 3.7980
Fibonacci 61.8% 2.9545
Fibonacci 50% 2.6940
Fibonacci 38.2% 2.4335
Last Price 1.9400
52-Week Low 1.5900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar